Footnotes

Footnotes

Chapter 1

[1]        Journals of the Senate, No. 33—19 June 2014, pp 914 – 915.

[2]        House of Representatives Hansard, 18 June 2014, p. 6.

[3]        National Health Amendment (Pharmaceutical Benefits) Bill 2014, Explanatory Memorandum, p. 2.

[4]        See: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs

[5]        Department of Health, About the PBS, http://www.pbs.gov.au/info/about-the-pbs (accessed 2 July 2014).

[6]        Department of Health, About the PBS, http://www.pbs.gov.au/info/about-the-pbs (accessed 18 July 2014).

[7]        Department of Veterans' Affairs, Repatriation Pharmaceutical Benefits Scheme, http://www.dva.gov.au/service_providers/doctors/Pages/rpbs.aspx (accessed 2 July 2014)

[8]        Item 3 of Schedule 1 Bill, paragraphs 99G(2)(a) and 99G(2)(b).

[9]        Item 1 of Schedule 1 and Item 1 of Schedules 2, 3, and 4.

[10]      Item 3 of Schedule 1 and Item 1 of Schedule 5; Explanatory Memorandum, p. 1.

[11]      Senate Standing Committee for the Scrutiny of Bills, Alert Digest No. 7, 25 June 2014, p. 34.

[12]      Parliamentary Joint Committee on Human Rights, Eighth Report of the 44th Parliament; Bills introduced 2 – 19 June 2014; Legislative Instruments received 31 May – 6 June 2014, p. 24.

[13]      Parliamentary Joint Committee on Human Rights, Eighth Report of the 44th Parliament; Bills introduced 2 – 19 June 2014; Legislative Instruments received 31 May – 6 June 2014, p. 24.     

Chapter 2 - Key issues

[1]        See: Grattan Institute, Submission 2; Council of Social Services New South Wales (NCOSS), Submission 3; HSU National, Submission 6; Consumer Health Forum of Australia, Submission 8.

[2]        Submission 8, p. 4.

[3]        House of Representatives Hansard, 18 June 2014.

[4]        Submission 4, p. 1.

[5]        Committee Hansard, 19 August 2014, p. 28.

[6]        Submission 12, p. 3.

[7]        Department of Health, Submission 12, p. 3.

[8]        See for example: Pharmacy Guild of Australia, Submission 1, p. 1.

[9]        See for example: Youth Affairs Council of South Australia, Submission 5, p. 5; Consumers Health Forum of Australia, Submission 8, p. 2; Council of Social Service NSW, Committee Hansard, 19 August 2014, p. 2.

[10]      Submission 3, p. 3.

[11]      Submission 3, p. 3.

[12]      Submission 8, p. 1.

[13]       Ms Felicity McNeill, Committee Hansard, 19 August 2014, p. 28

[14]      Submission 8, p. 2.

[15]      Committee Hansard, 19 August 2014, p. 29.

[16]      Submission 12, p. 4.

[17]      Submission 12, p. 4.

[18]      Submission 12, p. 4.

[19]      Department of Health, Strengthening Medicare, http://www.health.gov.au/internet/budget/publishing.nsf/content/budget2014-factsheet-strengthening-medicare, (accessed 21 August 2014).

[20]      Submission 2, p. 4.

[21]      Committee Hansard, 19 August 2014, p. 19.

[22]      Submission 2, p. 4.

[23]      Committee Hansard, 19 August 2014, p. 30.

[24]      Submission 4, p. 1.

[25]      Submission 9, p. [1].

[26]      Submission 8, p. 2.

[27]      Committee Hansard, 19 August 2014, p. 29.

[28]      Australian Council of Social Service, Committee Hansard, 19 August 2014, p. 2.

[29]      Submission 2, p. 9.

[30]      Submission 2, p. 10.

[31]      COTA, Submission 10, p. 4.

[32]      Committee Hansard, 19 August 2014, p. 35. The National Health Act 1953 provides that listed drugs be assigned to formularies identified as F1 or F2. Generally F1 is intended for single brand drugs and F2 for drugs that have multiple brands, or are in a therapeutic group with other drugs with multiple brands. Drugs on F2 are subject to the provisions of the Act relating to statutory price reductions, price disclosure and guarantee of supply.

[33]      Committee Hansard, 19 August 2014, p. 28.

[34]      Committee Hansard, 19 August 2014, p. 29.

Dissenting Report from the Australian Labor Party

[1]        Parliamentary Joint Committee on Human Rights, Eighth Report of the 44th Parliament, p. 24.

[2]        Submission 8, p. 2.

[3]        Submission 1, p. 3.

[4]        Submission 7, p. 2.

[5]        Submission 10, p. 3.

[6]        Submission 10. p. 4.

[7]        Supplementary Submission 2, p. 3.

[8]        http://www.pbs.gov.au/info/healthpro/explanatory-notes/front/fee#1

[9]        Committee Hansard, 19 August 2014, p. 9.

[10]      Committee Hansard, 19 August 2014, p. 9.

[11]      Submission 2, p. 1.

[12]      Committee Hansard, 19 August 2014, p. 25.

[13]      Submission 12, p. 7.

[14]      Committee Hansard, 19 August 2014, p. 28.

[15]      Submission 7, p. 2.

Greens’ Senators Dissenting Report

[1]        Sydney Morning Herald, 23 Aug 2014.

[2]        Submission 4, p. 1.

[3]        Submission  2, p. 1.

[4]        Submission 2, p. 1.

[5]        Submission 4, p. 2.

[6]        See: Grattan Institute, Submission 2; Council of Social Services New South Wales (NCOSS), Submission 3; HSU National, Submission 6; Consumer Health Forum of Australia, Submission 8.

[7]        Submission 3.

[8]        Submission 10, pp. 3-4.

[9]        Submission 10, p. 3.

[10]      Submission 8, p. 2.

[11]      Submission 8, p. 3.

[12]      Submission 2, p. 4.

[13]      Submission 4, p. 1.